EP3204040
TREATMENT OF CANCER USING TLR9 AGONISTS AND CHECKPOINT INHIBITORS
:
EP einkaleyfi: Þýðing ekki lögð inn:
9.10.2015:
8.12.2021:
15848691.0
:
8.10.2035
:
TREATMENT OF CANCER USING TLR9 AGONISTS AND CHECKPOINT INHIBITORS
9.10.2015
8.12.2021
:
Idera Pharmaceuticals, Inc.:
167 Sidney Street, Cambridge, MA 02319, US
:
WANG, Daqing:
Bedford, MA 01730, US
:
JIANG, Wayne:
Waltham, MA 02452, US
:
AGRAWAL, Sudhir:
Shrewsbury, MA 01545, US
:
201462062274 P:
10.10.2014:
US
:
201562218934 P:
15.9.2015:
US
:
US2015054899:
9.10.2015
:
A61K 31/7115, A61K 39/00, A61K 39/39, A61K 45/06, A61K 9/00, C07K 14/435, A61N 5/00, A61P 35/00, A61P 35/02, A61P 35/04, A61P 43/00